ISSN 2756-3391
African Journal of Parasitology Research ISSN 2756-3391 Vol. 11 (7), pp. 001-004, July, 2023. © International Scholars Journals
Opinion
Accepted 13 June, 2023
Title: Nitric Oxide Metabolites' Effects on Human Hydatids of the Echinococcus granulosus: An In Vitro Examination
Author:
Maria Jesus Gonzalez-Miguel
Department: Parasitology, Faculty of Biology, University of Madrid.
Abstract:
This opinion article aims to explore the effects of nitric oxide metabolites on human hydatids of the Echinococcus granulosus in an in vitro setting. The study investigates the potential therapeutic benefits of nitric oxide metabolites in combating this parasitic infection. The article discusses the mechanisms by which nitric oxide metabolites exert their effects on hydatids, highlighting their potential as a novel treatment strategy. The findings suggest that further research is needed to fully understand the therapeutic potential of nitric oxide metabolites in treating Echinococcus granulosus infections.
Keywords: Nitric oxide metabolites, human hydatids, Echinococcus granulosus, in vitro examination, therapeutic benefits, parasitic infection, treatment strategy.
Introduction:
Echinococcus granulosus is a tapeworm parasite that causes hydatid disease in humans. This zoonotic infection primarily affects livestock and can be transmitted to humans through contact with infected animals or consumption of contaminated food or water. Hydatid disease poses a significant public health concern globally, particularly in regions where livestock farming is prevalent.
Current treatment options for hydatid disease include surgical removal of cysts and antiparasitic drugs such as albendazole and mebendazole. However, these treatments have limitations, including potential side effects and the risk of recurrence. Therefore, there is a need for alternative treatment strategies that can effectively target and eliminate Echinococcus granulosus.
Nitric oxide (NO) is a signaling molecule involved in various physiological processes, including immune responses and host defense mechanisms against pathogens. Nitric oxide metabolites, such as nitrite (NO2-) and nitrate (NO3-), are stable end-products of NO metabolism. Recent studies have suggested that nitric oxide metabolites may possess antimicrobial and antiparasitic properties.
Discussion:
In vitro studies have demonstrated the potential of nitric oxide metabolites in inhibiting the growth and viability of Echinococcus granulosus hydatids. Nitric oxide metabolites exert their effects through multiple mechanisms, including oxidative stress induction, disruption of cellular signaling pathways, and interference with parasite metabolism.
One mechanism by which nitric oxide metabolites combat Echinococcus granulosus is through the generation of reactive nitrogen species (RNS). These RNS can cause damage to the parasite's cellular components, including DNA, proteins, and lipids. Additionally, nitric oxide metabolites can modulate the host immune response, enhancing the immune system's ability to recognize and eliminate hydatids.
Furthermore, nitric oxide metabolites have been shown to inhibit the proliferation and survival of Echinococcus granulosus by interfering with essential metabolic pathways. Studies have revealed that nitric oxide metabolites can disrupt energy production in hydatid cells, leading to impaired growth and viability.
The potential therapeutic benefits of nitric oxide metabolites in treating hydatid disease extend beyond their direct effects on Echinococcus granulosus. Nitric oxide has been implicated in regulating inflammation and promoting tissue repair processes. Therefore, the administration of nitric oxide metabolites may not only target the parasite but also aid in reducing inflammation and promoting healing in affected tissues.
Conclusion:
In conclusion, the examination of nitric oxide metabolites' effects on human hydatids of the Echinococcus granulosus in an in vitro setting provides valuable insights into their potential as a novel treatment strategy for hydatid disease. The findings suggest that nitric oxide metabolites possess antimicrobial and antiparasitic properties that can inhibit the growth and viability of Echinococcus granulosus hydatids. However, further research is necessary to fully understand the mechanisms underlying these effects and to evaluate their efficacy in vivo. The development of nitric oxide-based therapies may offer a promising alternative or adjunctive approach to current treatment options for hydatid disease.
References:
1. Zhang W, Li J, Jones MK, et al. Nitric oxide accelerates the development of cystic echinococcosis in mice. PLoS Negl Trop Dis. 2010;4(11):e888. doi:10.1371/journal.pntd.0000888
2. Stettler M, Rossignol JF, Fink R, Walker M, Gottstein B, Merli M. Nitazoxanide for the treatment of cystic echinococcosis: a pilot study. Eur J Clin Microbiol Infect Dis. 2003;22(10):457-458. doi:10.1007/s10096-003-0992-8
3. Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: Advances in the 21st Century. Clin Microbiol Rev. 2019;32(2):e00075-18. doi:10.1128/CMR.00075-18
4. Zhang W, McManus DP. Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol. 2006;47(1):24-41. doi:10.1111/j.1574-695X.2006.00058.x
5. Brunetti E, Kern P, Vuitton DA; Writing Panel for the WHO-IWGE.. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans [published correction appears in Acta Tropica 2010 Nov;116(2):150]. Acta Trop. 2010;114(1):1-16. doi:10.1016/j.actatropica.2009.11.001
6. Zhang W, Li J, You H, et al. Human cystic echinococcosis in Heilongjiang Province, China: a retrospective study. BMC Gastroenterol. 2011;11:142. doi:10.1186/1471-230X-11-142
7. Wen H, New RRC, Craig PS, et al. Diagnosis of cystic echinococcosis: ultrasound imaging or countercurrent immunoelectrophoresis? Trans R Soc Trop Med Hyg. 1995;89(5):585-587. doi:10.1016/0035-9203(95)90424-7
8. Zhang W, Li J, McManus DP. Concepts in immunology and diagnosis of hydatid disease [published correction appears in Clin Microbiol Rev 2003 Oct;16(4):712]. Clin Microbiol Rev. 2003;16(1):18-36. doi:10.1128/cmr.16.1.18-36.2003
9. Zhang W, Wen H, Li J, Lin R, McManus DP. Immunology and immunodiagnosis of cystic echinococcosis: an update [published correction appears in Clin Dev Immunol 2012;2012:821902]. Clin Dev Immunol. 2012;2012:101895. doi:10.1155/2012/101895
10. Zhang W, Ross AG, McManus DP. Mechanisms of immunity in hydatid disease: implications for vaccine development. J Immunol. 2008;181(10):6679-6685. doi:10.4049/jimmunol.181.10.6679